High TPMT activity as a risk factor for severe myelosuppression during thiopurine therapy

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)222-223
JournalNetherlands Journal of Medicine
Volume71
Issue number4
Publication statusPublished - 2013

Cite this